Empirico's unique internal capabilities in human genetics and siRNA medicines, augmented by those of our partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs.
Pipeline
Program
Therapeutic Area
Modality
Discovery
Preclinical
IND-Enabling
Phase 1
Partners
Program: EMP-012
Therapeutic Area: COPD & Other Respiratory Diseases
Modality: 
siRNA
- GalNAc
siRNA- GalNAc
Phase 1
Partner: 
Program: EMP-CNS
Therapeutic Area: Neurodegeneration & Neuroinflammation
Modality: siRNA
- GalNAc
- Extrahepatic
siRNA- GalNAc
- Extrahepatic
IND-Enabling
Partner:
Program: EMP-CVM
Therapeutic Area: Cardiovascular & Metabolic
Modality: siRNA
- GalNAc
- Extrahepatic
siRNA- GalNAc
- Extrahepatic
IND-Enabling
Partner:
Program: EMP-I&I
Therapeutic Area: Immunology & Inflammation
Modality: siRNA
- GalNAc
- Extrahepatic
siRNA- GalNAc
- Extrahepatic
IND-Enabling
Partner:
Program: EMP-MSK
Therapeutic Area: Musculoskeletal
Modality: siRNA
- Extrahepatic
siRNA- Extrahepatic
IND-Enabling
Partner: